Opaleye Management »

Crescent Biopharma shares owned by Opaleye Management

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Opaleye Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $14M 1.2M 11.86

More positions owned by Opaleye Management

Harrow Health (HROW)
Liquidia Corporation Com New (LQDA)
Eton Pharmaceuticals (ETON)
Rhythm Pharmaceuticals (RYTM)
Apogee Therapeutics (APGE)
Sanuwave Health (SNWV)
Stoke Therapeutics (STOK)
Ocular Therapeutix (OCUL)
Sol Gel Technologies Shs New (SLGL)
Cg Oncology (CGON)
Tg Therapeutics (TGTX)
Disc Medicine (IRON)
Rezolute Com New (RZLT)
Crescent Biopharma (CBIO)
Alkermes SHS (ALKS)

View all positions for Opaleye Management

Top funds holding Crescent Biopharma

Fairmount Funds Management
VR Adviser
FMR
BVF
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Deep Track Capital
Boxer Capital Management
Perceptive Advisors
Commodore Capital
Rtw Investments
Driehaus Capital Management

View all funds holding Crescent Biopharma